Humanigen, Inc. Is Effective Today
Aug 07, 2017 11:00 am UTC| Business
BRISBANE, Calif., Aug. 07, 2017 -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, today announced that its new name is effective. ...
Amicus Therapeutics Announces Second Quarter 2017 Financial Results and Corporate Updates
Aug 07, 2017 11:00 am UTC| Business
179 Fabry Disease Patients on Reimbursed Galafold (migalastat) as of July 31 – On Target to Reach 300 Patients by Year-End 2017 Migalastat NDA Submission Targeted for 4Q17 Phase 3 EB Topline Data and...
Chimerix Announces Second Quarter 2017 Financial Results
Aug 07, 2017 11:00 am UTC| Business
DURHAM, N.C., Aug. 07, 2017 -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today reported financial results and provided a corporate update for the...
Aug 07, 2017 11:00 am UTC| Business
HOUSTON, Aug. 07, 2017 -- Oncolix, Inc., a clinical-stage biotechnology company developing Prolanta™ for the treatment of ovarian cancer, today announced the completion of a merger between Oncolix and a wholly-owned...
Aug 07, 2017 11:00 am UTC| Business
SOUTH SAN FRANCISCO, Calif., Aug. 07, 2017 -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor...
Aug 07, 2017 11:00 am UTC| Business
Phase 2 Study Met Primary and Key Secondary Endpoints Results from First Patient Cohort of PIONEER-HCM Accepted for Oral Presentation at Heart Failure Society of America’s 21st Annual Scientific Meeting Enrollment...
Asterias Biotherapeutics to Present at Canaccord Genuity Growth Conference on August 10, 2017
Aug 07, 2017 11:00 am UTC| Business
FREMONT, Calif., Aug. 07, 2017 -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced that Mike Mulroy, President and Chief Executive...